|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6980 EUR | +36.59% |
|
+23.76% | -54.56% |
| 07-13 | AB Science to Discontinue Three Masitinib-related Clinical Studies | MT |
| 07-10 | AB Science streamlines its portfolio and refocuses on two molecules |  |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 0.898 | 0.898 | 0.895 |
| Spread/Res. | -22.27% | -22.27% | -22.01% |
| Spread/Supp. | +36.59% | +36.59% | +36.59% |
| Support | 0.511 | 0.511 | 0.511 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- AB Stock
- Charts AB Science
Select your edition
All financial news and data tailored to specific country editions
